This free sheet contains 100 accelerators and incubators you can apply to today, along with information about the industries they generally invest in.
This free sheet contains all the information about the top 100 unicorns, including their valuation, HQ's location, founded year, name of founders, funding amount and number of employees.
This free Notion document contains the best 100+ resources you need for building a successful startup, divided in 4 categories: Fundraising, People, Product, and Growth.
Shanghai's startup scene shows considerable strength in sectors like AI, robotics, and healthcare. The city hosts a mix of well-funded new companies and established market leaders.
Social e-commerce platform Xiaohongshu has raised over $917 million to date. In comparison, robotics company Agibot, founded in 2023, secured CN¥600M in its initial seed round.
Below is our list of 100 Shanghai startups worth keeping an eye on.
Everything you need to raise funding for your startup, including 3,500+ investors, 7 tools, 18 templates and 3 learning resources.
Buy It For $97 $297 →Information about the industries, countries, and cities they generally invest in.
Get the Sheet for $50Information about their valuation, HQ's location, founded year, name of founders, funding amount and number of employees.
Get the Sheet for $50List of startup investors in the BioTech, Health, and Medicine industries, along with their Twitter, LinkedIn, and email addresses.
Get the Sheet for $50List of 250 startup investors in the AI and Machine Learning industries, along with their Twitter, LinkedIn, and email addresses.
Get the Sheet for $50List of 250 startup investors in the FinTech and Finance industries, along with their Twitter, LinkedIn, and email addresses.
Get the Sheet for $50Agibot builds humanoid robots capable of performing complex, real-world tasks. Their systems are designed for multi-robot collaboration, particularly within industrial and manufacturing environments.
Xiaohongshu built a popular social commerce platform where users share product reviews and discover new lifestyle trends. Their app integrates user-generated content with a seamless shopping experience, making it a go-to destination for community-driven purchasing.
Biren Technology develops general-purpose GPUs and other intelligent processors built for AI and high-performance computing. Their hardware is designed to accelerate complex workloads within data centers using advanced GPU and DSA computation architectures.
Full-Life Technologies develops radiopharmaceutical medicines for cancer therapy. They manage the entire drug lifecycle, from initial research and development through to production and commercialization.
Smartee Denti-Technology develops clear dental aligners using its own digital orthodontics platform and 3D technology. They provide a range of invisible orthodontic treatments and are a leading brand within China's dental care market.
Ronovo Surgical builds robotic platforms to advance minimally invasive surgery. Their core system, Carina, is a modular and configurable tool designed to assist surgeons in a wide range of laparoscopic procedures.
Epigenic Therapeutics develops gene modulation therapies that treat diseases by regulating epigenetic mechanisms. The company uses its proprietary platform to control gene expression without altering the underlying DNA sequence.
MetaX builds high-performance general-purpose GPU chips for heterogeneous computing in data centers. Their hardware is designed to accelerate demanding workloads in AI, cloud computing, and the metaverse.
United Imaging Healthcare develops and manufactures a full portfolio of advanced medical imaging and radiotherapy equipment. The company provides a range of systems, including PET/CT, MR, and CT scanners, designed to help clinicians improve patient care and diagnostic capabilities.
Fourier Intelligence builds robotic systems and exoskeletons for the medical rehabilitation industry. Their technology helps patients recover motor functions and mobility through intelligent physical therapy platforms.
Our top 10 picks only scratch the surface of what's happening in Shanghai. Founders across the city are tackling big ideas in areas like AI, biotech, and mobility, raising billions of dollars along the way.
Some of these companies are brand new, while others are already well on their way. Here’s a look at the other startups that are shaping the city's future.
| Startup | Industry | Year Founded | Amount Raised | Last Funding Round |
|---|---|---|---|---|
| Media | 2016 | $401.6M | Series D | |
| Biotech | 2021 | CN¥500M | Series B | |
| Energy | 2008 | $175M | Debt Financing | |
| Biotech | 2021 | $160M | Seed | |
| Mobility | 2021 | CN¥500M | Series B | |
| Biotech | 2017 | $278.5M | Series A | |
| Mobility | 2014 | CN¥26.4B | Venture Round | |
| Fintech | 2017 | $168M | Series D | |
| AI | 2018 | CN¥5.1B | Series D | |
| Mobility | 2015 | $5.3B | Series D | |
| Media | 2016 | $2B | Corporate Round | |
| Mobility | 2025 | $242M | Seed | |
| Healthcare | 2017 | CN¥1B | Series A | |
| Gaming | 2017 | CN¥7M | Angel | |
| Enterprise | 2015 | CN¥313.9M | Series B | |
| Biotech | 2018 | $204M | Series C | |
| Healthcare | 2017 | $308M | Private Equity | |
| Enterprise | 2011 | CN¥247.5M | Venture Round | |
| Biotech | 2018 | CN¥100M | Series C | |
| Fintech | — | $116.5M | Debt Financing | |
| AI | 2025 | CN¥40M | Series A | |
| Healthcare | 2021 | CN¥1B | Series A | |
| AI | 2017 | CN¥151M | Series B | |
| Biotech | 2021 | CN¥177M | Series B | |
| Mobility | 2016 | $6.5M | Product Crowdfunding | |
| Manufacturing | 2007 | CN¥500M | Series D | |
| Automation | 2017 | CN¥1.2B | Series C | |
| AI | 2021 | $25.2M | Series A | |
| Mobility | 2024 | CN¥23M | Seed | |
| Hardware | 2020 | CN¥200M | Corporate Round | |
| Food | 2019 | $73.6M | Series B | |
| Logistics | 2018 | CN¥200M | Series B | |
| AI | 2016 | CN¥450M | Series C | |
| Fashion | 2017 | $60.4M | Venture Round | |
| Retail | 2020 | $30M | Seed | |
| Healthcare | 1989 | $7.6M | Series B | |
| AI | 2023 | $1.5M | Seed | |
| Healthcare | 2017 | CN¥150M | Series A | |
| Biotech | 2018 | $29M | Venture Round | |
| Energy | 2002 | CN¥100M | Venture Round | |
| Mobility | 2017 | $50M | Series B | |
| Mobility | 2016 | CN¥703M | Series B | |
| Hardware | 1998 | CN¥488M | Series F | |
| Enterprise | 2010 | $77.2M | Series B | |
| Sports | 2008 | $41.3M | Series D | |
| Enterprise | 2015 | $100M | Series C | |
| Hardware | 2016 | $98M | Series B | |
| AI | 2015 | $15.1M | Series C | |
| AI | 2016 | CN¥808M | Series D | |
| Retail | 2017 | $89.4M | Series B | |
| Retail | 2015 | CN¥1.5B | Series C | |
| Manufacturing | 2019 | $36.9M | Series A | |
| Hardware | 2011 | $244.4M | Series B | |
| Manufacturing | 1998 | $999.3M | Venture Round | |
| Hardware | 2020 | $231.1M | Series B | |
| AI | 2015 | CN¥210M | Series D | |
| AI | 2012 | CN¥200M | Series C | |
| Biotech | 2015 | CN¥400M | Series C | |
| AI | 2023 | $3M | Venture Round | |
| AI | 2025 | CN¥3B | Corporate Round | |
| Mobility | 2021 | $403M | Series A | |
| AI | 2018 | $10M | Series B | |
| Enterprise | 2004 | CN¥1.2B | Series D | |
| Manufacturing | 2022 | CN¥250M | Series A | |
| Food | 2017 | $551.8M | Venture Round | |
| Enterprise | 2015 | $34.8M | Series B | |
| Media | 2014 | $105.2M | Series C | |
| Retail | 2011 | $27.7M | Series D | |
| Marketing | 2019 | CN¥199M | Series B | |
| Biotech | 2017 | CN¥309M | Series C | |
| Retail | 2024 | $26.4M | Angel | |
| Mobility | 2021 | CN¥100M | Series A | |
| Healthcare | 2020 | CN¥100M | Series A | |
| Manufacturing | 2022 | CN¥200M | Venture Round | |
| Fashion | 2017 | CN¥720M | Venture Round | |
| Healthcare | 2019 | CN¥200M | Series C | |
| Media | 2014 | $10M | Series A | |
| Biotech | 2012 | $69.7M | Series D | |
| Healthcare | 2014 | CN¥138M | Series B | |
| AI | 2018 | CN¥100M | Venture Round | |
| Food | 2011 | CN¥800M | Series B | |
| Cloud | 2022 | $29.2M | Series A | |
| Media | 2009 | CN¥150M | Series B | |
| AI | 2017 | $11.5M | Series A | |
| Healthcare | 2004 | $138.4M | Series D | |
| Fashion | 1988 | CN¥200M | Series A | |
| Enterprise | 2021 | CN¥100M | Seed | |
| Media | 2018 | $33.7M | Series A | |
| Biotech | 2020 | CN¥920M | Seed | |
| Food | 2020 | $50M | Venture Round |
